Is Methylene Blue Safe to Take Orally? Who Should Avoid It

Is methylene blue safe to take orally? It depends mostly on who you are and what else you take. This guide covers who should not take it, the drug interactions, G6PD deficiency, pregnancy, kidney function, dose-related risk, and daily use. For what the normal side effects look like, see our guide to oral methylene blue side effects.

• The serotonin interaction is the hard line. The FDA label for methylene blue injection (Provayblue) carries a boxed warning that combining it with serotonergic medications, including SSRIs, SNRIs and MAOIs, and with opioids may cause serious or fatal serotonin syndrome.
• Some people should not take it at all. The Provayblue label lists G6PD deficiency and severe hypersensitivity as contraindications, and warns that it may cause fetal harm in pregnancy.
• Dose decides most of the other risk. StatPearls puts the clinical thresholds for adverse effects far above a supplement serving, but that gap is not an invitation to take more.
• Daily long-term use is not well studied. Most human research is single-dose, so long-term daily use is a decision to make with your healthcare provider.

Important: The FDA label for methylene blue injection (Provayblue) carries a boxed warning about serotonin syndrome with serotonergic medications, including SSRIs and MAOIs. See our Adverse Medications List before use.

Blue or green urine, mild nausea and an early headache are the common side effects, and the Provayblue prescribing information tells patients to expect blue discoloration of the skin and body fluids. What each side effect looks like, how common it is, and the warning signs of serotonin syndrome are in our oral methylene blue side effects guide. This guide covers the bigger question: who should not take methylene blue, and what makes it risky.

This is the main reason methylene blue is not safe for some people. Ramsay and colleagues (British Journal of Pharmacology, 2007) found methylene blue to be a potent inhibitor of monoamine oxidase A (MAO-A), confirming what had been predicted. Gillman explains that an MAO-A inhibitor combined with serotonergic drugs can produce serotonin syndrome, which can be fatal.

Which Medications Carry This Risk

The Provayblue label boxed warning names SSRIs, SNRIs, MAOIs and opioids, and its drug interactions section also names bupropion, buspirone, clomipramine, mirtazapine, linezolid and dextromethorphan. The FDA's drug safety communication lists serotonergic psychiatric medications including trazodone and tricyclic antidepressants. Our adverse medications list shows Drugs.com rating St. John's Wort, 5-HTP and L-tryptophan as major interactions. Every drug class is laid out in our methylene blue drug interactions guide.

For what serotonin syndrome looks like, see the warning signs in our side effects guide. If you have those signs after taking methylene blue, treat it as a medical emergency.

Does Dose Matter for This Interaction?

Probably, but nobody knows where a safe line is. The FDA Drug Safety Communication notes that most reported cases involved intravenous doses of 1 to 8 mg/kg in surgical settings, and that the risk at lower oral doses is less well characterized. MAO-A inhibition is still a property of the compound at any dose. A 12mg capsule in a 75kg adult is about 0.16 mg/kg, well below where most cases were reported, but that makes the combination unstudied, not safe.

Beyond the serotonin risk, several groups should be careful or avoid methylene blue entirely. Some of these, like G6PD deficiency, are more common than people expect.

G6PD Deficiency

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic condition that affects how red blood cells handle oxidative stress. It is one of the most common inherited enzyme deficiencies globally, particularly prevalent in people of African, Mediterranean, Middle Eastern, and South Asian descent. The FDA label for Provayblue warns that in people with this condition, methylene blue can trigger hemolytic anemia, where red blood cells break down faster than the body can replace them, and lists G6PD deficiency as a contraindication. If you have never been tested and have family history from these populations, ask your doctor before starting. More detail: methylene blue and G6PD deficiency.

Pregnancy and Breastfeeding

Methylene blue is not appropriate during pregnancy. The Provayblue label reports that methylene blue given before birth has caused hyperbilirubinemia, hemolytic anemia, skin staining, and respiratory distress in newborns. The label also advises stopping breastfeeding for up to 8 days after treatment. If you are pregnant or nursing, do not take methylene blue. More detail: methylene blue in pregnancy and breastfeeding.

Renal Impairment

The kidneys handle a large share of methylene blue. The Provayblue label reports that total exposure rose by 52 percent with mild kidney impairment and by 192 percent with severe impairment after a single dose. Older adults are more likely to have reduced kidney function. If you have any diagnosed kidney condition, consult a healthcare provider before starting.

Known Hypersensitivity

The Provayblue label lists severe allergic reactions, including anaphylaxis, among its warnings and makes known hypersensitivity a contraindication. If you get hives, swelling, trouble breathing, or a rapid whole-body reaction after a dose, stop and seek medical care.

Methemoglobin Reductase Deficiency

Methemoglobin reductase deficiency is a rare condition that prevents the body from properly reducing methemoglobin. StatPearls lists it as a contraindication, because this reduction pathway is part of how methylene blue works, so in these people it may not work and may cause harm.

Dose governs almost everything here because most of the alarming side effect data comes from intravenous hospital use at 1 to 8 mg/kg, and most articles skip that. When a peer-reviewed paper reports hypertension, chest pain, or hemolysis as adverse effects, it is almost always describing patients who received hospital-administered IV methylene blue at doses used for treating methemoglobinemia or vasoplegic shock. Those doses bear almost no relationship to a 12mg oral supplement capsule.

That does not make low doses consequence-free. It means reading the data in context. Bruchey and Gonzalez-Lima (2008), at the University of Texas at Austin, describe a hormetic dose-response for methylene blue: in lab work, low doses supported mitochondrial function and high doses shifted toward pro-oxidant effects. Low and high doses are not the same thing, so the results of one do not carry over to the other.

What this means practically: the side effects most people will actually encounter at standard supplemental doses are the mild, temporary, expected reactions covered earlier in this article. The serious adverse effects documented in clinical literature are overwhelmingly associated with high-dose intravenous administration in hospital settings, not 12mg oral capsules taken at home. The exception is the serotonin interaction, which does not scale neatly with dose, so we treat it as applying at any amount.

So do not take more than your label says because of social media or the idea that more is better. Above a supplement serving, the safety data come from monitored medical use, and the hormetic research suggests more is not simply more of the same.

There is no long-term safety study of daily methylene blue in healthy adults that we can point to. Most of the human research is single-dose. Rodriguez and colleagues (Radiology, 2016) gave one 280mg oral dose in a brain-imaging trial, and Telch and colleagues (American Journal of Psychiatry, 2014) gave one 260mg dose after an exposure-therapy session.

The longest trial in our references is Alda and colleagues (British Journal of Psychiatry, 2017), a 6-month double-blind crossover study in 37 patients with bipolar disorder who were also taking lamotrigine. It compared a 15mg dose with a 195mg dose, and the authors reported that the medication was well tolerated, with transient and mild side effects. That was a supervised trial in a specific patient group, not a study of supplement users.

For how each Nutricel formula is meant to be taken, see how to take methylene blue.

Yes. StatPearls, the clinical reference published on the NCBI Bookshelf, states that methylene blue is generally well tolerated at therapeutic doses below 2 mg/kg and that doses exceeding 7 mg/kg are associated with a markedly increased risk of adverse effects. It also reports hypotension, wheezing, and reduced oxygenation at single doses of 3 mg/kg or more. Those figures describe medical use under monitoring, not supplements.

StatPearls lists nausea, vomiting, chest pain, shortness of breath, and a rapid heart rate among the effects reported at cumulative doses of 7 mg/kg or more. If you notice any of these after taking methylene blue, stop and seek medical care.

The serotonin interaction is the exception to all of this. It is a drug-combination risk, not a dose threshold, so a small amount is not a safe amount if you take a serotonergic medication. Check yours on the adverse medications list.

It depends on which source you read. The FDA label for Provayblue states that methylene blue has a half-life of approximately 24 hours in humans. A smaller study of seven volunteers (Peter et al., European Journal of Clinical Pharmacology, 2000) estimated a terminal half-life of 5.25 hours in whole blood after intravenous dosing.

Pharmacologists usually treat a compound as cleared after about five half-lives. Using those two published figures, that puts clearance somewhere between roughly one day and five days, and the oral figure is not firmly established. Oral methylene blue is absorbed well: Walter-Sack and colleagues (European Journal of Clinical Pharmacology, 2009) measured an absolute bioavailability of about 72 percent in 16 healthy volunteers.

Do not use a half-life to work out your own gap between methylene blue and a serotonergic medication. Stopping, starting, or spacing a prescription is a decision for your healthcare provider. For the full timeline, see how long methylene blue stays in your system.

No. Methylene blue sold for aquariums is a fish treatment. It is not made, tested, or labeled for people, and nothing on the bottle tells you its purity or what else is in it. The same applies to methylene blue sold as a laboratory stain or a textile dye.

Only USP-grade methylene blue is appropriate for human use. USP-grade means the material meets the United States Pharmacopeia monograph for identity, purity, and contaminants. It does not mean a product is "USP certified," and a seller making that claim is using the term incorrectly.

Whatever brand you buy, look for a third-party lab report you can actually open. Our real vs fake checklist covers what to look for, and the lab and water test database listed results for 166 products as of October 7, 2026.

Read this part first, whether you use drops or capsules. Each line below names its source. The FDA prescribing information for Provayblue (methylene blue injection) was written about IV hospital use, so read it as what that label says, not as advice from us.

• SSRIs, SNRIs, MAOIs and opioids, including tramadol. The Provayblue label boxed warning says to avoid using them with methylene blue because of the risk of serious or fatal serotonin syndrome.
• Bupropion, buspirone, clomipramine, mirtazapine, linezolid and dextromethorphan. The Provayblue label names each of these in its drug interactions section.
• St. John's Wort, 5-HTP and L-tryptophan. Our adverse medications list shows Drugs.com rating each of these as a major interaction with methylene blue.
• G6PD deficiency. The Provayblue label lists it as a contraindication because of the risk of hemolytic anemia.
• Pregnancy and breastfeeding. The Provayblue label says it may cause fetal harm and advises stopping breastfeeding for up to 8 days after treatment.

For any drug not named here, look it up on the full adverse medications list, and talk to your healthcare provider before starting methylene blue in any form.

Every Nutricel product uses USP-grade methylene blue, is made in an GMP certified facility in the United States, and our capsules have third-party lab results published on the third-party tests page. The difference between them is what goes in alongside the methylene blue.

Blue Boost is our core formula: 12mg of methylene blue per capsule with Vitamin C Ester and organic cacao. If you mainly want methylene blue itself, start here.

Blue Immune combines methylene blue with copper, NAC, grass-fed beef liver, and vitamins A, C, and E for cellular and immune function support.

Blue Shroom pairs methylene blue with six organic mushroom extracts including lion's mane, reishi, cordyceps, chaga, shiitake, and turkey tail.

Blue Renew is built around GlyNAC (glycine and N-acetyl cysteine), studied for supporting glutathione levels and brain function in aging populations.

Blue Remove combines zeolite, curcumin, and nattokinase, aimed at circulation and the body's normal inflammatory response.

Blue Liquid is USP-grade methylene blue in a dropper bottle (1%, 10mg per mL), for people who prefer liquid and want to adjust in small steps.

Whether methylene blue is safe for you comes down to three things: what else you take, who you are, and how much you take. The common side effects, like blue urine, are covered in our side effects guide. This guide is about the lines that matter more.

The non-negotiable line is serotonin syndrome. Ramsay and colleagues (2007) describe methylene blue as a potent MAO-A inhibitor. We treat that as applying to any dose or route, not just hospital IV doses. If you take no serotonergic drugs and have checked the full adverse medications list with your provider, a supplement serving sits far below the doses where StatPearls reports most adverse effects. That is not the same as a long-term safety study, which does not exist yet.

Purity matters more here than almost anywhere else in supplements. The dose benchmarks in this article assume pharmaceutical-grade USP methylene blue, not industrial or lab-grade material made without those contaminant limits. If your supplement has no published lab report from an ISO/IEC 17025-accredited lab, you cannot really apply these thresholds to what you are taking.

Blue Boost contains 12mg USP-grade methylene blue per capsule, and its third-party lab report is published on the Nutricel certifications page. Before starting, review the full adverse medications list and confirm with your healthcare provider that no contraindications apply to your situation.

Clinical Pharmacology and Toxicology

Serotonin Syndrome and Drug Interactions

Further Reading

Sam Carlson, Marketing Developer at Nutricel

Sam is a marketing developer at Nutricel who writes the Nutricel Insights series to help our customers understand methylene blue and make informed choices, translating the published research into plain language. Sam is not a medical professional, and these articles are intended as education rather than medical advice. Every figure in this piece is tied to the studies listed in the references, and you should always speak with your healthcare provider before starting any supplement.